IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Gnh India Pharmaceuticals IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Mumbai and caters to Pharmaceutical sector. Gretex Corporate Services is the merchant banker of Gnh India Pharmaceuticals IPO. It is a SME UPCOMING IPO which filed its Draft Red Herring Prospectus (DRHP) on 21st September 2024.
Gnh India Pharmaceuticals IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].Gnh India Pharmaceuticals IPO size is Rs [●] crores with IPO price of Rs [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Gretex Corporate Services Limited is the book-running lead manager of the Gnh India Pharmaceuticals IPO. Purva Sharegistry (India) Private Limited is the Registrar and Market Maker is [●] for Gnh India Pharmaceuticals IPO.
Gnh India Pharmaceuticals IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Gnh India Pharmaceuticals IPO, based in Mumbai, operates in the Pharmaceutical sector with a focus on . The company is launching its SME UPCOMING IPO on the NSE EMERGE exchange, using the Book Building Issue method. Gnh India Pharmaceuticals IPO size is ₹ [●] Crores with fresh issue size of Rs [●] Crores and Offer for sale being Nil.
The IPO allotment date for Gnh India Pharmaceuticals IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Gnh India Pharmaceuticals IPO allotment status on the registrars website, Purva Sharegistry (India) Private Limited. Gnh India Pharmaceuticals IPO refund dates are [●].
Gnh India Pharmaceuticals IPO is expected to be listed on [●].
The upper price band for the Gnh India Pharmaceuticals IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Gnh India Pharmaceuticals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Gnh India Pharmaceuticals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Gnh India Pharmaceuticals IPO is finalised.
The merchant banker for Gnh India Pharmaceuticals IPO is Gretex Corporate Services Limited . Gretex Corporate Services Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Gnh India Pharmaceuticals IPO RHP for further details.
The registrar for Gnh India Pharmaceuticals IPO is Purva Sharegistry (India) Private Limited. Investors can go to Purva Sharegistry (India) Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Gnh India Pharmaceuticals IPO through their official website or helpline.
Gnh India Pharmaceuticals IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
[●]
Sector: Pharmaceutical
SME IPO so far:
34
Merchant Banker:
Gretex Corporate
SME IPO by BRLM so far:
47
City:
Mumbai
SME IPO so far:
48
Revenue (annualised):
₹ 40.02 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: [●]
Gnh India Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Gnh India Pharmaceuticals Financial Review Page
Merchant Banker(s) of Gnh India Pharmaceuticals IPO: Gretex Corporate Services Limited
Gnh India Pharmaceuticals IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Gnh India Pharmaceuticals IPO listed at a listing price of against the offer price of .
The current market price of Gnh India Pharmaceuticals is .
Why Us?
